全文获取类型
收费全文 | 12129篇 |
免费 | 663篇 |
国内免费 | 460篇 |
专业分类
耳鼻咽喉 | 40篇 |
儿科学 | 269篇 |
妇产科学 | 79篇 |
基础医学 | 1504篇 |
口腔科学 | 139篇 |
临床医学 | 1126篇 |
内科学 | 2455篇 |
皮肤病学 | 140篇 |
神经病学 | 593篇 |
特种医学 | 195篇 |
外科学 | 651篇 |
综合类 | 1815篇 |
预防医学 | 663篇 |
眼科学 | 83篇 |
药学 | 2556篇 |
5篇 | |
中国医学 | 624篇 |
肿瘤学 | 315篇 |
出版年
2024年 | 13篇 |
2023年 | 81篇 |
2022年 | 223篇 |
2021年 | 325篇 |
2020年 | 332篇 |
2019年 | 220篇 |
2018年 | 291篇 |
2017年 | 263篇 |
2016年 | 335篇 |
2015年 | 284篇 |
2014年 | 580篇 |
2013年 | 873篇 |
2012年 | 591篇 |
2011年 | 699篇 |
2010年 | 552篇 |
2009年 | 512篇 |
2008年 | 584篇 |
2007年 | 573篇 |
2006年 | 546篇 |
2005年 | 524篇 |
2004年 | 474篇 |
2003年 | 437篇 |
2002年 | 390篇 |
2001年 | 328篇 |
2000年 | 321篇 |
1999年 | 287篇 |
1998年 | 231篇 |
1997年 | 237篇 |
1996年 | 225篇 |
1995年 | 192篇 |
1994年 | 176篇 |
1993年 | 152篇 |
1992年 | 152篇 |
1991年 | 128篇 |
1990年 | 126篇 |
1989年 | 112篇 |
1988年 | 107篇 |
1987年 | 90篇 |
1986年 | 84篇 |
1985年 | 105篇 |
1984年 | 114篇 |
1983年 | 65篇 |
1982年 | 70篇 |
1981年 | 52篇 |
1980年 | 51篇 |
1979年 | 26篇 |
1978年 | 31篇 |
1977年 | 26篇 |
1976年 | 17篇 |
1974年 | 15篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
Harold P. Schedl Helen D. Wilson Ron L. Horst Karla Christensen Kice Brown 《Nutrition Research》1992,12(12):1541-1547
The circulating concentration of 1,25-dihydroxycholecalciferol [1,25-(OH)2D3] is a physiologic index of enzymatic activity of the renal 1-hydroxylase of 25-hydroxychole-calciferol (25-OH-D3). Hydroxylation of 25-OH-D3 and circulating 1,25-(OH)2D3 are decreased in the streptozotocin diabetic rat. We previously found that activity of another redox enzyme system, cytosolic superoxide dismutase, also decreased in streptozotocin diabetes, can be restored by treatment with glutathione. In the present experiment we tested the effect of glutathione treatment on vitamin D metabolism in control and diabetic rats. Enteral glutathione increased circulating 1,25-(OH)2D3 and decreased 25-OH-D3 in both control and diabetic animals. These results suggest that exogenous glutathione increases 25-OH-D3 1-hydroxylation both under basal conditions in the normal animal and in diabetes-induced depression. 相似文献
42.
目的:观察ARB-valsartan及ACEI-benazeprilat能否抑制由AngⅡ、PDGF引起的SHR肾小球系膜细胞的增殖与肥大。且比较单用时作用孰强孰弱,联合应用后有无协同效应。方法;采用经典SHR系膜细胞培养技术,细胞中加入各种因子和(或)药物,以^3H-leucine或^3H-thymidine掺入后的cpm值反映蛋白或DNA合成。采用t test检验差异的显著性。结果:1、系膜细胞在AngⅡ、PDGF刺激后引起的增殖与肥大,均可被valsartan及benazeprilat抑制。2、比较发现单一用药在同一浓度下,valsartan较benazeprilat能更有效地抑制细胞的增殖与肥大。3、联合用药在同一浓度valsartan benazeprilat均比单用valsartan或benazeprilat效果明显。结论:1、valsartan与benazeprilat均能抑制SHR系膜细胞的增殖与肥大。2、valsartan在抗系膜细胞增殖与肥大作用稍强于benazeprilat。3、在一定浓度条件下联合用药对抗系膜细胞的增殖与肥大作用,较单一用药效果明显。 相似文献
43.
本实验将赖型钩端螺旋体(简称钩体)DNA基因库的克隆pCX7制备成 ̄(32)P-重组DNA探针,对8个不同血清群的17株问号状钩体、双曲钩体PatocⅠ株以及细螺旋体3055株DNA进行打点杂交;同时用15种DNA片断进行限制性内切酶谱分析。结果表明,该重组DNA具有问号状钩体种(Species)特异性,但与不同问号状钩体之间的同源性程度有差别;限制性内切酶谱分析发现pCX7重组DNA片段长约1.7kb,具有1个Bg1Ⅱ识别位点和3个BstB1识别位点。 相似文献
44.
目的评估伊那普利治疗糖尿病肾病(DN)的临床疗效 ,并探讨其作用机制。方法40例持续微量蛋白尿的非胰岛素依赖型糖尿病(NIDDM)患者随机分为常规治疗组(n=19)和伊那普利治疗组(n=21)。利用 131I -邻碘马尿酸钠测定有效肾血浆流量(ERPF) ;肾小球滤过率(GFR)以内生肌酐清除率表示 ;通过ELISA法测定尿微量蛋白 ,包括白蛋白(ALB)、转铁蛋白(TF)、视黄醇结合蛋白(RBP)和N -乙酰 - β氨基葡萄糖苷酶(NAG)。结果伊那普利治疗组增高的尿ALB、TF、RBP和NAG均显著下降 ;ERPF显著增加 ;增加的滤过分数(FF)显著减低。而常规治疗组这些参数无显著变化。结论伊那普利具有改善DN患者的肾小球血流动力学 ,保护肾小球和肾小管功能的作用 相似文献
45.
Peter J. Harris Jialong Zhuo Sandford L. Skinner 《Clinical and experimental pharmacology & physiology》1987,14(6):489-502
1. The role of angiotensin as a modulator of proximal glomerulotubular (GT) balance was investigated in anaesthetized rats by examining the relationship between glomerular filtration rate (GFR) and absolute proximal reabsorption (APR) during removal of endogenous angiotensin II (AII) and III (AIII) with enalaprilat (CEI) and then during their subsequent replacement by intravenous infusions. 2. Enalaprilat lowered mean arterial blood pressure (MABP) and increased renal blood flow (RBF), GFR, urine flow rate and sodium excretion. Filtration fraction (FF) was not altered. Absolute proximal reabsorption, derived from fractional lithium clearance, increased by only 48% of the change expected for 'perfect' GT balance. 3. Angiotensin II replacement corrected MABP, GFR and plasma renin level, but reduced RBF and increased FF; APR was decreased and GT balance was restored. Urine flow and sodium excretion remained above control values with AII. 4. Replacement with AIII did not correct the hypotension but completely reversed the renal and renin responses to enalaprilat and restored GT balance without affecting FF. 5. It was concluded that the relation between proximal reabsorption and GFR is considerably modified by the intrarenal angiotensin concentration. The findings are best explained by a direct stimulation of proximal tubular sodium transport by angiotensin at the concentrations existing in anaesthetized rats. 相似文献
46.
E. T. Whalley Y. O. Amure R. H. Lye 《Naunyn-Schmiedeberg's archives of pharmacology》1987,335(4):433-437
Summary Bradykinin (BK) initially produced concentration-related relaxations of human basilar artery in vitro. Concentration-effect curves constructed at 2 h intervals to BK over an 8 h period were reproducible. The rank order of potency of three kinins on the human basilar artery was found to be BK > methionyl-lysyl-BK > des-Arg9-BK. The B2-receptor antagonist Thi5,8
d-Phe7-BK but not the B1-receptor antagonist des-Arg9-Leu8-BK selectively blocked BK-induced relaxations of the human basilar artery.The relaxant effects of bradykinin and acetylcholine but not papaverine were attenuated after removal of the endothelium or treating the tissues with BW755C. Indomethacin was without effect. Concentration-effect curves to angiotensin I were markedly attenuated by captopril at a concentration which had no effect on BK, angiotensin II or 5-hydroxytryptamine responses. It is concluded that BK induced relaxations of the human basilar artery are mediated via activation of a B2 receptor and the response is dependent upon the release of a factor present in the endothelium. Angiotensin converting enzyme is present in the human basilar artery and is important for the conversion of angiotensin I to angiotensin II but apparently not for the degradation of BK. It is likely that other kininases are present and active in the tissue.
Send offprint requests to E. T. Whalley at the above address 相似文献
47.
48.
目的探讨工程菌表达的耐热DNA聚合酶的纯化方法。②方法收集IPTG诱导带有耐热DNA聚合酶(TD聚合酶)基因表达质粒的工程菌株DH-TD4,用溶菌酶裂解,60℃处理后,上清液用硫酸铵沉淀,根据溶解度差异进行粗分级,然后进行离子交换层析细分级,并经聚合酶链式反应(PCR扩增)鉴定其活性。③结果纯化的TD聚合酶具有良好的聚合活性。④结论溶解度差异与离子交换层析是工程菌表达的耐热DNA聚合酶纯化的主要步骤。基因工程制备的DNA聚合酶可用于PCR检测 相似文献
49.
成人特发性乳糖酶缺乏症的发生率极高,这些人进食牛奶后会出现胃肠胀气、腹痛、腹泄等对牛奶不耐受的消化不良症状。为解决这一问题,自1989年起,国内外不少学者是主张有产替代疗法,即将人工培养制备纯化的乳糖酶直接加入牛奶中以水解其中的乳糖来弥补成人乳糖酶的缺乏。 相似文献
50.
Claire Corot Jean-Marc Idee Anne-Marie Hentsch Robin Santus Catherine Mallet Valrie Goulas Bruno Bonnemain Dominique Meyer 《Journal of magnetic resonance imaging : JMRI》1998,8(3):695-702
Transmetallation between commercially available solutions of gadolinium (Gd) chelates and the zinc (Zn)-dependent angiotensin-converting enzyme (ACE) was investigated. In vitro, the strongest inhibitions were observed for the linear Gd complexes, Gd diethylene-triamine pentaacetic acid (DTPA) bis-methylamide (BMA) (IC50 = .016 ± .006 mmol/1) and Gd-DTPA (IC50 = .350 ± .034 mmol/1). The two macrocycles Gd tetraazacyclododecane tetraacetic acid (DOTA) and Gd-HP-DO3A were similar and 400 times less active than Gd-DTPA-BMA. These effects were mainly due to the presence of free ligand for DTPA and calcium (Ca) chelate in the case of DTPA-BMA because the addition of Zn2+ in the same quantities suppresses their inhibitory effects. In vivo, these two solutions of linear Gd chelates significantly inhibited ACE activity (Gd-DTPA: 67 ± 9% versus baseline; and Gd-DTPA-BMA: 73 ± 2% versus baseline at the clinical dose of .1 mmol/kg), whereas no significant effect was observed for the two macrocyclic chelates Gd-DOTA and Gd-HP-DO3A. Formulating the Gd chelate solution with either an excess of free ligand or Ca chelate (to decrease Gd3+ release) in the case of linear Gd chelate may have deleterious biologic consequences. 相似文献